Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-24

Clinical Trial Update: Development of Products Based on Secretom From Stem Cell Conditioned Medium for Melasma Therapy [NA]

View source ↗

Summary

Clinical trial evaluating products based on secretome from stem cell conditioned medium for melasma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Secretom from stem cell conditioned medium

Snippet

Sponsor: Dr.dr.Irma Bernadette, SpKK (K) | Conditions: Melasma | NA | Status: RECRUITING